There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small cell lung cancer is often categorized in one of two stages: limited or ...
The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca, today announced that two research awards ...
Despite recent advances in immunotherapy and targeted therapy, most patients with non-small-cell lung cancer (NSCLC) continue to have disease progression and develop resistance to current treatments.
New T-cell engagers and ADCs show survival gains in pretreated small cell lung cancer, signaling long-awaited progress and more treatment options for patients. New therapies like T-cell engagers and ...
Most people with small cell lung cancer will have a recurrence. While several factors affect life expectancy, the outlook is typically less favorable. Treatment for recurrent small cell lung cancer is ...
Chemotherapy is a treatment that may be used for non-small cell lung cancer. It’s often used in combination with other treatment types. Chemotherapy is associated with a variety of risks and benefits.
Early-stage non-small cell lung cancer (NSCLC) has a better prognosis than advanced stages. Staging the disease helps inform treatment by factoring in tumor size, lymph node involvement, and spread.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results